0001104659-20-033114.txt : 20200313 0001104659-20-033114.hdr.sgml : 20200313 20200313160745 ACCESSION NUMBER: 0001104659-20-033114 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200101 FILED AS OF DATE: 20200313 DATE AS OF CHANGE: 20200313 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lorenz Kevin CENTRAL INDEX KEY: 0001772558 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35366 FILM NUMBER: 20712703 MAIL ADDRESS: STREET 1: C/O NUVEEN STREET 2: 333 W. WACKER DR. CITY: CHICAGO STATE: IL ZIP: 60606 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Fortress Biotech, Inc. CENTRAL INDEX KEY: 0001429260 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 205157386 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2 GANSEVOORT STREET STREET 2: 9TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10014 BUSINESS PHONE: 781-652-4500 MAIL ADDRESS: STREET 1: 2 GANSEVOORT STREET STREET 2: 9TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10014 FORMER COMPANY: FORMER CONFORMED NAME: CORONADO BIOSCIENCES INC DATE OF NAME CHANGE: 20080310 4 1 tm2011481-5_form4.xml FORM 4 X0306 4 2020-01-01 0 0001429260 Fortress Biotech, Inc. FBIO 0001772558 Lorenz Kevin C/O FORTRESS BIOTECH, INC. 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NY 10014 1 0 0 0 COMMON STOCK, PAR VALUE $0.001 2020-01-01 4 P 0 50000 0.00 A 164582 D One-third of the shares will vest on each of January 1, 2021, 2022 and 2023, subject to continued service. Includes 34,582 shares owned by Mr. Lorenz prior to his appointment to the Company's board in August 2019. /s/ Samuel Berry / Attorney-in-Fact 2020-03-13